The imCORE network: Experts collaborating to fight cancerHow collaboration between academia and industry is improving chances of finding cures for cancerDecember 20, 2023
Reducing the risk of lung cancer returningApproximately half of people with early-stage NSCLC still experience a cancer recurrence following surgery. This video explains how doctors try to reduce the risk of lung cancer returningOctober 19, 2023
Confronting a melanoma diagnosis as a pathologist and patientDr. Tom Grogan has spent a lifetime discovering smarter, safer, better ways to diagnose cancer. That’s why his own diagnosis of malignant melanoma came as a shock.October 05, 2022
Discover Roche’s latest innovations in cancer immunotherapyRoche scientists discuss their work at the cutting edge of cancer immunotherapy researchDecember 16, 2021
The cancer immunity cycleA new framework is redefining how we implement personalised cancer immunotherapy research around the world.November 03, 2021
Introducing cancer immunotherapyIn recent years progress has been made in developing cancer immunotherapies that target specific aspects of an individual’s tumour.November 03, 2021
Rewriting the book on immunotherapyLearn how biomarkers take the stage in helping doctors diagnose cancer.November 03, 2021
Beyond the immunity cycleRoche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.November 03, 2021
Our approach to cancer immunotherapyRoche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.November 03, 2021
Fighting cancer using a novel cell engineering technologyExample of how Roche Partnering collaborates with a Partner company in the field of cell engineering.November 03, 2021
Ever wondered how patient outcomes are measured in clinical trials?Today, approaches that measure cancer treatment are more comprehensive – they look to extend patients’ lives and maintain quality of life.November 03, 2021